Excessive Phlebotomy in Cardiac Surgical Care Leads to Anemia
|
By LabMedica International staff writers Posted on 01 Apr 2015 |

Image: Phlebotomy or venipuncture performed to obtain blood for laboratory tests (Photo courtesy of Sweet Water Health and Education).
Laboratory testing among patients undergoing cardiac surgery can lead to excessive bloodletting, which can increase the risk of developing hospital-acquired anemia and the need for blood transfusion.
Health care providers are seldom aware of the frequency and volume of phlebotomy for laboratory testing, bloodletting that often leads to nosocomial anemia. The frequency of laboratory testing in patients undergoing cardiac surgery, and the cumulative phlebotomy volume from time of initial surgical consultation to hospital discharge has been investigated.
Medical teams at the Cleveland Clinic (Cleveland, OH, USA) examined every laboratory test from 1,894 patients who underwent cardiac surgery from January to June 2012. The number and type of blood tests performed were recorded from the time patients met their surgeons until hospital discharge. The scientists then tallied up the total amount of blood taken from each patient. Phlebotomy volume was estimated separately for the intensive care unit (ICU), hospital floors, and cumulatively.
A total of 221,498 laboratory tests were performed, averaging 115 tests per patient. The most frequently performed tests were 88,068 blood gas analyses, 39,535 coagulation tests, 30,421 complete blood counts, and 29,374 metabolic panels. Phlebotomy volume differed between ICU and hospital floors, with median volumes of 332 mL and 118 mL, respectively. Cumulative median volume for the entire hospital stay was 454 mL. More complex procedures were associated with higher overall phlebotomy volume than isolated procedures. Foe combined coronary artery bypass grafting (CABG) and valve procedure, the median volume was 653 mL versus 448 mL for isolated CABG and 338 mL for isolated valve procedures.
Colleen G. Koch, MD, MS, MBA, the lead author of the study said, “We were astonished by the amount of blood taken from our patients for laboratory testing. Total phlebotomy volumes approached one to two units of red blood cells, which is roughly equivalent to one to two cans of carbonated beverage. Patients should feel empowered to ask their doctors whether a specific test is necessary, such as: What is the indication for the test? Will it change my care? And if so, do you need to do it every day? They should inquire whether smaller volume test tubes could be used for the tests that are deemed necessary. Every attempt should be made to conserve the patient's own blood, every drop of blood counts.” The study was published in the March 2015 issue of the journal the Annals of Thoracic Surgery.
Related Links:
Cleveland Clinic
Health care providers are seldom aware of the frequency and volume of phlebotomy for laboratory testing, bloodletting that often leads to nosocomial anemia. The frequency of laboratory testing in patients undergoing cardiac surgery, and the cumulative phlebotomy volume from time of initial surgical consultation to hospital discharge has been investigated.
Medical teams at the Cleveland Clinic (Cleveland, OH, USA) examined every laboratory test from 1,894 patients who underwent cardiac surgery from January to June 2012. The number and type of blood tests performed were recorded from the time patients met their surgeons until hospital discharge. The scientists then tallied up the total amount of blood taken from each patient. Phlebotomy volume was estimated separately for the intensive care unit (ICU), hospital floors, and cumulatively.
A total of 221,498 laboratory tests were performed, averaging 115 tests per patient. The most frequently performed tests were 88,068 blood gas analyses, 39,535 coagulation tests, 30,421 complete blood counts, and 29,374 metabolic panels. Phlebotomy volume differed between ICU and hospital floors, with median volumes of 332 mL and 118 mL, respectively. Cumulative median volume for the entire hospital stay was 454 mL. More complex procedures were associated with higher overall phlebotomy volume than isolated procedures. Foe combined coronary artery bypass grafting (CABG) and valve procedure, the median volume was 653 mL versus 448 mL for isolated CABG and 338 mL for isolated valve procedures.
Colleen G. Koch, MD, MS, MBA, the lead author of the study said, “We were astonished by the amount of blood taken from our patients for laboratory testing. Total phlebotomy volumes approached one to two units of red blood cells, which is roughly equivalent to one to two cans of carbonated beverage. Patients should feel empowered to ask their doctors whether a specific test is necessary, such as: What is the indication for the test? Will it change my care? And if so, do you need to do it every day? They should inquire whether smaller volume test tubes could be used for the tests that are deemed necessary. Every attempt should be made to conserve the patient's own blood, every drop of blood counts.” The study was published in the March 2015 issue of the journal the Annals of Thoracic Surgery.
Related Links:
Cleveland Clinic
Latest Clinical Chem. News
- New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
- Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
- Study Compares Analytical Performance of Quantitative Hepatitis B Surface Antigen Assays
- Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
- Compact Raman Imaging System Detects Subtle Tumor Signals
- Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics
- POC Breath Diagnostic System to Detect Pneumonia-Causing Pathogens
- Online Tool Detects Drug Exposure Directly from Patient Samples
- Chemical Imaging Probe Could Track and Treat Prostate Cancer
- Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
- VOCs Show Promise for Early Multi-Cancer Detection
- Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
- Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
- Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
- Simple Non-Invasive Hair-Based Test Could Speed ALS Diagnosis
- Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







